Clint Narver Partner

Clint joins McGuireWoods after serving as an assistant director of the United States Department of Justice (DOJ) Consumer Protection Branch, where he personally conducted and supervised complex healthcare and economic crime prosecutions. Clint developed particular expertise in handling corporate criminal investigations and litigation in the healthcare and life sciences sectors, including as to pharmaceuticals and medical devices, research misconduct and clinical trial fraud, drug diversion and supply chain integrity, grant fraud, healthcare fraud, kickbacks, and pharmacy compounding. Clint’s work included extensive collaboration with the DOJ Civil Fraud Section on qui tam (whistleblower) False Claims Act investigations.

Before his tenure at the DOJ, Clint served in various capacities with the FDA’s Office of the Chief Counsel, where he supported the agency’s Health Care Fraud and Abuse Control (HCFAC) program and worked closely with the Center for Drug Evaluation and Research (CDER), the Center for Devices and Radiological Health (CDRH), and the Office of Criminal Investigations (OCI). Clint advised on drug and device research, application integrity, manufacturing (including cGMP and QSR requirements), advertising and promotion, and safety reporting, as well as on food, dietary supplement, and tobacco product regulation. Clint also handled criminal jury trials and appeals while serving as a Special Assistant U.S. Attorney in multiple jurisdictions, and participated in research misconduct investigations involving the HHS Office of Research Integrity.

Clint’s unique background enables him to provide insightful and practical advice to clients facing regulatory challenges. His proactive approach helps clients address potential issues before they escalate, ensuring compliance and minimizing risk. In situations where the government pursues enforcement action, Clint leverages his extensive prosecutorial experience to aggressively defend his clients’ rights in litigation.